The peroxisome is a small organelle present in almost all cells. The peroxisomal disorders are a newly recognized group of disease entities that share structural and/or functional abnormalities of the peroxisomes, are inherited, and may have profound neurologic and systemic effects. Some of the disorders lack peroxisomes in cells, while others have single or multiple peroxisomal enzymatic deficiencies despite the presence of normally appearing peroxisomes. The prototype of the peroxisomal disorders is Zellweger syndrome. X-linked adrenoleukodystrophy, neonatal adrenoleukodystrophy, infantile Refsum disease, hyperpipecolic acidemia and Refsum disease are some of the other disease entities presently classified as peroxisomal disorders. Accurate methods of pre- and postnatal diagnosis are available. Treatment strategies are being developed, but at this time prenatal diagnosis and appropriate genetic counseling is the best therapeutic intervention for those peroxisomal disorders characterized by profound neurologic handicap and early death.
Get full access to this article
View all access options for this article.
References
1.
Rhodin J.Correlation of ultrastructural organization and function in normal and experimentally changed proximal convoluted tubule cells of the mouse kidney. Doctoral thesis , 1954. Karolinska Institute, Stockholm.
2.
de Duve C.Microbodies in the living cell. Sci Am1983 ;248:74-84.
3.
Schutgens Rbh , Heymans Hsa, Wanders Rja, et al. Peroxisomal disorders: a newly recognised group of genetic diseases. Eur J Pediatr1986 ;144:430-40.
4.
Tolbert E.Metabolic pathways in peroxisomes and glyoxysomes. Annu Rev Biochem1981;50:133-57.
5.
Lazarow PB, de Duve C.A fatty acyl-CoA oxidizing system in rat liver peroxisomes: enhancement by clofibrate, a hypolipidemic drug. Proc Natl Acad Sci USA1976;73:2043-6.
6.
Bowen P., Lee Csn, Zellweger H., et al. A familial syndrome of multiple congenital defects. Bull Hopkins Hosp1964; 114:402-14.
7.
Goldfischer S., Moore CL, Johnson AB, et al. Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome. Science1973;182:62-4.
8.
Aubourgh P., Robain O, Rocchiccioli, et al. The cerebro-hepato-renal (Zellweger) syndrome: lamellar lipid profiles in adrenocortical, hepatic mesenchymal, astrocyte cells and increased levels of very long chain fatty acids and phytanic acid in the plasma. J Neurol Sci1985;69:9-25.
9.
Arias JA, Moser AB, Goldfischer SLUltrastructural and cytochemical demonstration of peroxisomes in cultured fibroblasts from patients with peroxisomal deficiency disorders. J Cell Biol1985; 100:1789-92.
10.
Kelley RIThe cerebro-hepato-renal syndrome of Zellweger morphologic and metabolic aspects . Am J Med Genet1983;16:503-17.
11.
Mooi WJ, Dingemans KP, van den Bergh MA, et al. Ultrastructure of the liver in the cerebro-hepato-renal syndrome of Zellweger. Ultrastruct Pathol1983;5:135-44.
12.
Versmold HT , Bremer HJ, Herzog V., et al. Metabolic disorder similar to Zellweger syndrome with hepatic acatalesia and absence of peroxisomes, altered content and redox state of cytochromes, and infantile cirrhosis with hemosiderosis . Eur J Pediatr1977;124:261-75.
13.
Wanders Rja , Kos M., Roest B., et al. Activity of peroxisomal enzymes and intracellular distribution of catalase in Zellweger syndrome. Biochem Biophys Res Commun1984;123:1054-61.
14.
Trijbels JM , Berden JA, Monnens Lah, et al. Biochemical studies in the cerebro-hepato-renal syndrome of Zellweger: a defect in the electron-transport chain possibly caused by a deficiency of peroxisomes. Pediatr Res1983;17:514-7.
Aebi HE, Wyss SRAcatalasemia. In: Stanbury JB, Wijngaarden JB, Frederickson DS, eds. The metabolic basis of inherited disease. New York: McGraw-Hill, 1978:1792-1802.
17.
Moser AE, Singh I., Brown FR III, et al. The cerebro-hepato-renal (Zellweger) syndrome: increased levels and impaired degradation of very long chain fatty acids and their use in prenatal diagnosis. N Engl J Med1984;310:1141-6.
18.
Singh I., Moser AE, Goldfischer S., et al. Lignoceric acid is oxidized in the peroxisome: implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy. Proc Natl Acad Sci USA1984;81:4203-7.
19.
Lazarow PBRat liver peroxisomes catalyse the beta-oxidation of fatty acids. J Biol Chem1978;253:1522-8.
20.
Osmundsen DHPeroxisomal beta-oxidation of long chain fatty acids: effects of high fat diets. Ann NY Acad Sci1982;386:13-9.
21.
Goldfischer S., Collins J., Rapin I., et al. Peroxisomal defects in neonatal-onset and X-linked adrenoleukodystrophies. Science1984;227:67-70.
22.
Jaffe R., Crumrine P., Hashida Y., et al. Neonatal adrenoleucodystrophy: clinical, pathologic, and biochemical delineation of a syndrome affecting both males and females. Am J Pathol1982;108:100-11.
23.
Kelly RI, Datta NS, Dobyns WB, et al. Neonatal adrenoleukodystrophy: new cases, biochemical studies, and differentiation from Zellweger and related peroxisomal polydystrophy syndromes . Am J Med Genet1986;23:869-901.
24.
Moser HW, Moser AE, Singh I., et al. Adrenoleukodystrophy: survey of 303 cases; biochemistry, diagnosis and therapy. Ann Neurol1984;16:628-44.
25.
Wilson GN, Holmes RG, Custer J.Zellweger syndrome: diagnostic assays, syndrome delineation and potential therapy. Am J Med Genet1986;24:69-82.
26.
Moser HW, Moser AE, Trojak JE, et al. Identification of female carriers of adrenoleukodystrophy. J Pediatr1983;103:54-9.
27.
Datta NS, Wilson GN, Hajra AKDeficiency in enzymes catalyzing the biosynthesis of glycerol-ether lipids in Zellweger syndrome: a new category of metabolic disease involving the absence of peroxisomes. N Eng J Med1984;311:1080-3.
28.
Hajra AK, Burke CL, Jones CLSubcellular localisation of acyl coenzyme A: dihydro-acetone phosphate acyl transferase in rat liver peroxisomes (microbodies). J Biol Chem1979;254:10896-900.
29.
Roscher A., Molzer B., Bernheimer H., et al. The cerebro-hepato-renal (Zellweger) syndrome: an improved method for the biochemical diagnosis and its potential value for prenatal detection . Pediatr Res1985;19:930-3.
30.
Schutgens Rbh , Romeyn GJ, Wanders Rja, et al. Deficiency of acyl CoA: dihydroxyacetone phosphate acyl transferase in patients with Zellweger (cerebro-hepato-renal) syndrome. Biochem Biophys Res Commun1984; 120:179-84.
31.
Heymans Hsa , Schutgens Rbh, Tan R., et al. Severe plasmalogen deficiency in tissues of infants with peroxisomes (Zellweger syndrome). Nature1983;306:69-70.
32.
Roels F., Corneilis, F., Poll-The BTHepatic peroxisomes are deficient in infantile Refsum disease. Am J Med Genet1986;25:257-71.
33.
Hagey LR, Krisans SKDegradation of cholesterol to propionic acid by rat liver peroxisomes. Biochem Biophys Res Commun1982;107:834-41.
34.
Kase F., Bjorkhem I., Haga P., et al. Formation of cholic acid from 3,7,12-trihydroxy-5-cholestanoic acid in rat liver peroxisomes. J Lipid Res1983;24:1560-7.
35.
Monnens L., Bakkaren J., Parmentier G., et al. Disturbances in bile acid metabolism of infants with the Zellweger (cerebro-hepato-renal) syndrome. Eur J Pediatr1980;133: 31-5.
36.
Stokke O., Skrede S., Ek J., et al. Refsum's disease, adrenoleuco-dystrophy, and the Zellweger syndrome . Scand J Clin Lab Invest1984;44:463-4.
37.
Trijbels J. , Monnens L., Bakkaren J., et al. Biochemical studies in the cerebrohepatorenal syndrome of Zellweger: a disturbance in the metabolism of pipecolic acid. J Inherited Metab Dis1979;2:39-42.
38.
Budden SS, Kennaway NG, Buist Nrm, et al. Dysmorphic syndrome with phytanic acid oxidase deficiency, abnormal very long-chain fatty acids, and pipecolic acidemia: studies in four children . J Pediatr1986;108:33-9.
39.
Burton BK, Reeds SP, Remy WTHyperpipecolic acidemia: clinical and biochemical observations in two male siblings. J Pediatr1981;99:729-34.
40.
Danks DM, Tippet P., Adams C., et al. Cerebrohepatorenal syndrome of Zellweger. J Pediatr1975;86:382-7.
41.
Kelly RI, Moser HWHyperpipecolic acidemia in neonatal adrenoleukodystrophy. Am J Med Genet1984;19:791-5.
42.
Chang YHPipecolic acid pathway: the major lysine metabolite route in the rat brain . Biochem Biophys Res Commun1976;69:174-80.
43.
Van den Branden C., Vamecq J., Wybo I., et al. Phytol and peroxisome proliferation . Pediatr Res1986;20:411-5.
44.
Opitz JM, Zu Rhein GM, Vitale L., et al. The Zellweger syndrome (Cerebrohepatorenal syndrome). Birth Defects1969;2:144-58.
45.
Passarge E. , McAdams AJCerebro-hepato-renal syndrome: A newly recognized hereditary disorder of multiple congenital defects including sudanophilic leukodystrophy, cirrhosis of the liver and polycystic kidneys. J Pediatr1967;71:691-702.
46.
Smith DW, Opitz JM, Inhorn SLA syndrome of multiple developmental defects including polycystic kidneys and intrahepatic biliary dysgenesis in two siblings. J Pediatr1965;67:617-24.
47.
Agamanolis DP, Patre S.Glycogen accumulation in the central nervous system in the cerebro-hepato-renal syndrome. J Neurol Sci1979;41:325-42.
48.
Agamanolis DP, Robinson HB, Timmons GDThe cerebrohepatorenal syndrome: report of a case with histochemical and ultrastructural observations. J Neuropathol Exp Neurol1976;35:226-46.
49.
Williams JP , Secrest L., Fowler GW, et al. Roentgenographic features of the cerebro-hepato-renal syndrome of Zellweger. Am J Roentgenol Radium Ther Nucl Med1972; 115:607-10.
50.
Gilchrist KW , Gilbert EF, Goldfarb S., et al. Studies of malformation syndromes of man X1B: The cerebro-hepato-renal syndrome of Zellweger: comparative pathology . Eur J Pediatr1976;121:99-118.
51.
Goldfischer S., Powers JM, Johnson AB, et al. Striated adrenocortical cells in cerebro-hepato-renal (Zellweger) syndrome. Virchows Arch [Cell Pathol]1983;401:355-61.
52.
Govaerts L. , Monnens L., Melis T., et al. Disturbed adrenocortical function in cerebro-hepato-renal syndrome of Zellweger. Eur J Pediatr1984;143:10-2.
53.
Gatfield PD , Taller E., Hinton GG, et al. Hyperpipecolatemia: a new metabolic disorder associated with neuropathy and hepatomegaly. Can Med Assoc J1968;99:1215-33.
54.
Thomas GH, Haslam Rha, Batshaw ML, et al. Hyperpipecolic acidemia associated with hepatomegaly, mental retardation, optic nerve dysplasia, and progressive neurological disease. Clin Genet1975;8:376-82.
55.
Poulas A., Pollard AC, Mitchell JD, et al. Patterns of Refsum's disease: phytanic acid oxidase deficiency . Arch Dis Child1984;59:222-9.
56.
Scotto JM, Hadchouel M., Odievre M., et al. Infantile phytanic acid storage disease, a possible variant of Refsum's disease: three cases, including ultrastructural studies of the liver. J Inherited Metab Dis1982;5:83-90.
57.
Steinberg D., Avigan J., Mize C., et al. Conversion of U-C 14 phytol to phytanic acid and its oxidation in heredopathia atactica polyneuritiformis. Biochem Biophys Res Commun1965;19:783-9.
58.
Powell H., Tindall R., Schultz P., et al. Adrenoleukodystrophy: electron microscopic findings. Arch Neurol1975 ;32:250-60.
59.
Powers JM, Schaumburg HHAdrenoleukodystrophy: similar ultrastructural changes in adrenal cortical cells and Schwann cells. Arch Neurol1974;30:406-8.
60.
Schaumburg HH, Powers JH, Raine CS, et al. Adrenoleukodystrophy: a clinical and pathological study of 17 cases. Arch Neurol1975;32:577-91.
61.
Griffin JW, Goren E., Schaumburg H., et al. Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy . Neurology1977;27:1107-13.
62.
Singh I., Moser AB, Moser HW, et al. Adrenoleukodystrophy: impaired oxidation of very long chain fatty acids in white blood cells, cultured skin fibroblasts and amniocytes . Pediatr Res1984; 18:286-90.
63.
Van Duyn MA , Moser AE, Brown FR III, et al. The design of a diet restricted in saturated very long chain fatty aids: therapeutic application in adrenoleukodystrophy . Am J Clin Nutr1984;40:277-84.
64.
Rizzo WB, Phillips MWDietary oleic acid (C18:1) supplementation lowers plasma and erythrocyte hexacosanoate (C26:0) levels in adrenoleukodystrophy (ALD). Pediatr Res1986;20:271A.
65.
Gibberd FB, Page Ngr, Billimoria JD, et al. Heredopathia atactica polyneuritiformis (Refsum's disease) treated by diet and plasma exchange. Lancet1979;1:575-8.
66.
Penovich PE , Hollander J., Nusbacher JA, et al. Note on plasma exchange therapy in Refsum's disease. Adv Neurol1978;21:151-3.
67.
Moser HW, Tutschka PJ, Brown FR III, et al. Bone marrow transplant in adrenoleukodystrophy. Neurology1984;34:1410-7.
